Psychological Impact of COVID-19 Outbreak on Caregivers (PSY-CO-ICU)

December 3, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Psychological Impact of COVID-19 Outbreak on Caregivers Involved in Intensive Care Unit Patient Management: Impact on the Occurrence of Post-traumatic Stress Disorder, Anxiety, Depression and Burn Out Syndrome

Based on the experience of previous pandemics, countries reacted by applying different upgrade strategies to prevent or delay the widespread of the disease. Therefore, measures such as border closure, school closure, restrict social gathering (even shutdown of workplaces), limit population movements, and confinement meaning quarantines at the scale of cities or regions. In public hospitals, several measures have been decided to concentrate the power of care on potential wave of admissions of patients with severe forms of Covid-19. In this purpose, the number of available beds in Intensive Care Units (ICU) has been increased by two-fold and scheduled non-emergency surgical procedure have been cancelled. That means:

  1. For the most severe patients, new personals (physician such as anesthesiologists, nurses of other units) have been transferred in ICUs.
  2. For the less severe patients, personals of non-busy units have been transferred in busier ones.

All these measures lead to major daily-life change sets that could be stressful. In the general population, it has been well documented that quarantine or confinement or isolation could lead to the occurrence of Post-Traumatic Stress Disorder (PTSD) syndrome in about 30% overall population. Importantly, high depressive symptoms have been reported in 9% of hospital staff. Numerous symptoms have been reported after quarantine or isolation such as emotional disturbance, depression, stress, low mood, irritability, insomnia, and post-traumatic stress symptoms.

In hospital setting, few studies have been performed for assessing the psychological impact of quarantine and isolation. However, two studies reported a high prevalence of burn-out syndrome (BOS) in ICU physician and PTSD syndrome and depression in ICU nurses. As the consequences of all the measures decided and applied during Covid-19 pandemic could be important on caregivers, the present study primarily aims at assessing the prevalence of PTSD syndrome in a large population of caregivers implied or not in Intensive Care Units. The secondary objective were 1) to assess the prevalence of severe depression and anxiety and BOS 2) to isolate potential factors associated with PTSD, severe depression, anxiety or BOS.

Study Overview

Study Type

Observational

Enrollment (Actual)

701

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amiens, France, 80054
        • Intensive Care Unit, CHU d'Amiens
      • Angers, France, 49933
        • Intensive Care Unit, CHU d'Angers
      • Besançon, France, 25030
        • CHU de Besancon
      • Bordeaux, France, 33076
        • CHU de Bordeaux, Hôpital Pellegrin
      • Brest, France, 29609
        • Intensive care Unit CHU de Brest Hôpital Cavale Blanche
      • Caen, France, 14033
        • CHU de Caen
      • Clermont-Ferrand, France, 63003
        • Chu de Clermont Ferrand
      • Créteil, France, 94010
        • AP-HP, Hôpital Henri Mondor
      • Dijon, France, 21079
        • Chu de Dijon
      • La Tronche, France, 38700
        • CHU de Grenoble, Hôpital Michalon
      • Le Kremlin-Bicêtre, France, 94275
        • AP_HP, Hôpital du Kremlin Bicêtre
      • Lille, France, 59037
        • Intensive Care Unit, CHRU de Lille
      • Limoges, France, 87042
        • Intensive Care Unit, CHU de Limoges
      • Lyon, France, 69317
        • Hôpitaux civils de Lyon, Hôpital de la Croix Rousse
      • Lyon, France, 69394
        • Hôpitaux civils de Lyon, Hôpital Louis Pradel
      • Lyon, France, 69437
        • Hôpitaux civils de Lyon, Hôpital Edouard Herriot
      • Marseille, France, 13005
        • AP-HM, Hôpital Nord
      • Marseille, France, 13005
        • AP-HM, Hôpital Timone adultes, Intensive Care Unit
      • Marseille, France, 13015
        • AP-HM, Hôpital Timone adultes, Neurotraumatology
      • Marseille, France, 13385
        • AP-HM, Hôpital e la Conception
      • Montpellier, France, 34295
        • CHU de Montpellier, Hôpital Guy de chauliac
      • Montpellier, France, 34295
        • CHU de Montpellier, Hôpital Lapeyronie
      • Montpellier, France, 34295
        • CHU de Montpellier, Hôpital St Eloi SAR B
      • Montpellier, France, 34295
        • CHU De Montpellier, Hôpital St Eloi-DAR B
      • Montpellier, France, 34295
        • CHU De Montpellier, Hôpital St Eloi
      • Mulhouse, France, 68051
        • Intensive Care Unit, CHU de Mulhouse
      • Nancy, France, 54000
        • Intensive CAre Unit CHRU de Nancy, Hôpital Central
      • Nantes, France, 44093
        • Intensive Care Unit, CHU de Nantes, Hôtel Dieu
      • Nantes, France, 44093
        • Intensive Care Unit, CHU de Nantes
      • Nice, France, 06000
        • CHU de Nice
      • Nîmes, France, 30029
        • Intensive care Unit CHU Nîmes
      • Paris, France, 75013
        • AP-HP, Hôpital de la Pitié
      • Paris, France, 75018
        • AP-HP, Hôpital Bichât
      • Paris, France, 75475
        • AP-HP, Hôpital Lariboisière
      • Paris, France, 75475
        • AP6HP, Hôpital St Loui
      • Paris, France, 75908
        • AP_HP, Hôpital G Pompidou
      • Paris, France, 75970
        • AP-HP, Hôpital St Antoine
      • Perpignan, France, 66046
        • CH de Perpignan
      • Pessac, France, 33604
        • CHU de Bordeaux, Hôpital Haut Leveque
      • Pierre-Bénite, France, 69310
        • Intensive care Unit, Hôpitaux civils de Lyon, Lyon Sud
      • Poitiers, France, 86021
        • Chu de Poitiers
      • Rennes, France, 35033
        • Intensive care Unit CHU de Rennes
      • Rouen, France, 76031
        • CHU de Rouen
      • Saint-Etienne, France, 42055
        • CHU de St Etienne, Hôpital Nord
      • Saint-Herblain, France, 44800
        • Intensive Care Unit, CHU de Nantes, Hôpital Laennec
      • Strasbourg, France, 67091
        • Intesive Care Unit CHRU de Strasbourg, Hôpital civil
      • Strasbourg, France, 67098
        • Intesive Care Unit CHRU de Strasbourg, Hôpital Hautepierre
      • Toulouse, France, 31059
        • CHU de Toulouse
      • Tours, France, 37044
        • Intensive care unit CHU de Tours
      • Vandœuvre-lès-Nancy, France, 54511
        • Intensive CAre Unit CHRU de Nancy, Hôpital de Brabois
      • Vesoul, France, 70014
        • CH de Vesoul

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Caregivers (doctors senior and junior, nurses, aid nurses) involved in the staff (permanent or transient, full or partial time) of ICU patients during Covid-19 outbreak

Description

Inclusion Criteria:

  • Caregivers (doctors senior and junior, nurses, aid nurses) involved in the staff (permanent or transient, full or partial time) of ICU patients during Covid-19 outbreak
  • Approved to participate

Exclusion Criteria:

  • Participation refusal
  • No internet connection for responding to the questionnaire with REDCAP file

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Caregivers
• Caregivers (doctors senior and junior, nurses, aid nurses) involved in the staff (permanent or transient, full or partial time) of ICU patients during Covid-19 outbreak
assessment of post-traumatic stress, anxiety and burn out

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-Traumatic Stress Disorder
Time Frame: 3-6 month after the Covid-19 outbreak
PCL - 5 (Post-Traumatic Stress Disorder Checklist Scale, version DSM-5)
3-6 month after the Covid-19 outbreak

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anxiety and depression
Time Frame: 3-6 month after the Covid-19 outbreak
HADS scale (Hospital Anxiety and Depression Scale)
3-6 month after the Covid-19 outbreak
Burn out
Time Frame: 3-6 month after the Covid-19 outbreak
Score MBI (Burn out syndrome)
3-6 month after the Covid-19 outbreak

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean Yves LEFRANT, Centre Hospitalier Universitaire de Nimes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2021

Primary Completion (Actual)

July 20, 2022

Study Completion (Actual)

July 20, 2022

Study Registration Dates

First Submitted

August 12, 2020

First Submitted That Met QC Criteria

August 12, 2020

First Posted (Actual)

August 13, 2020

Study Record Updates

Last Update Posted (Actual)

December 10, 2025

Last Update Submitted That Met QC Criteria

December 3, 2025

Last Verified

December 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on questionnaire filling

Subscribe